media – Page 591 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

Nanochon Procures Fastest Growing Cartilage

A startup company called Nanochon secure 1st place at the 3DHEALS conference this year after delivering its pitch to a group of investors including Asimov Ventures, GE Ventures, Digital Industrialist.
- Source: Ddu
- 713
- May 29, 2018
3D printing Company Insight
Permethrin Clothing As An Effective Anti-Tick Measure

Recently, scientists from the Centre for Disease Control and Prevention (CDC) were encouraging people to soak their clothes in a chemical named permethrin. They discovered that only 25 percent of ticks were found alive even after 24 hours of exposure. But they were unaware of the fact regarding how long permethrin remained active in textiles.
- Source: Ddu
- 458
- May 29, 2018
health tips lyme disease Researches
Black Lung Disease – What to Know

A new form of the deadly disease named pneumoconiosis or black lung disease has become more prevalent especially among coal miners in the US, with mining experience of more than ten years.
- Source: Ddu
- 637
- May 29, 2018
lung disease Researches
Innovative New Method To Fight Cancer

The research study revealed that tumor growth could be reduced by targeting the expression of Beta3-integrin along with microtubule-targeting agents (MTAs) chemotherapy. Beta3-integrin was the better anti-angiogenic target since it was expressed in tumor blood vessels, unlike normal cells.
- Source: Ddu
- 766
- May 29, 2018
cancer Clinical Trials
Ingestible Sensor To Diagnose Gastrointestinal Diseases

To diagnose any kind of gastrointestinal problems, an ingestible sensor equipped with a genetically engineered bacteria was developed by an MIT research team. This ‘bacteria-on-a-chip’ combined sensors with ultra-low-power electronics, which could convert the bacterial response into a wireless signal that can be read by a smartphone.
- Source: drugdu
- 559
- May 29, 2018
digital health mHealth Researches
Drinking Too Much Water Could Harm You

It is always advised to drink water. But recent studies have shown that there may be a limit as to how much. Overconsumption of water causes a decrease in sodium levels and fluid accumulates excessively in the brain, which leads to its swelling. This life-threatening condition, termed as Hyponatremia, is more commonly prevalent among the elderly.
- Source: Ddu
- 491
- May 29, 2018
health tips Researches
Amyotrophic Lateral Sclerosis Patients Found New Hope

Lou Gehrig disease which has no cure is finally seeing a ray of hope by Tel Aviv University researchers. The disease also called Amyotrophic lateral sclerosis (ALS) a neurodegenerative issue which causes muscles to atrophy and produces permanent disability in patients. The investigators say they may have found the basis of what could become a treatment for the devastating disease.
- Source: Ddu
- 527
- May 28, 2018
ALS Researches
Virtual Doctor Visit As Effective As Personal Visit For Hypertension Patients

Recent research on abnormally high blood pressure hints virtual consulting is just as effectual in controlling hypertension as those conducted in person. The study was supervised by the researcher from Brigham & Women’s Hospital (B&W) and Massachusetts General Hospital (MGH).
- Source: Ddu
- 576
- May 28, 2018
digital health hypertension Researches
Healthcare Sector Has Not Fully Exploited Data Analytics Potential

India-based Omega Healthcare has categorically stated that the growth of data analytics and cloud intelligence firms in the Indian healthcare sector has little scope. The company plans to hire around 1,200 - 1,500 people for exploring emerging markets like the United Arab Emirates.
- Source: Ddu
- 803
- May 28, 2018
Company Insights digital health India
New Cancer Drug Of Eisai And Merck Stalled By FDA

In a major setback for Eisai and Merck & Co, the FDA has stalled the roll-out of Lenvima as a treatment for earlier untreated liver cancer patients. Big things were expected by Merck & Co when Eisai’s Lenvima was scheduled to be launched in March. Merck has agreed to shell out USD 5.8 billion on half of the liver cancer’s drug sales.
- Source: Ddu
- 772
- May 28, 2018
FDA Merck New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.